With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.1662-01-7,4,7-Diphenyl-1,10-phenanthroline,as a common compound, the synthetic route is as follows.
General procedure: The corresponding ligand (1mmol) was added to a MeCN solution (40mL) of the corresponding metal pivalate (1mmol). The resulting mixture was stirred at t=60C for 2h, filtered off, and slowly cooled to room temperature. The solution was kept at room temperature, and crystals precipitated for 6-48h. In some cases, single crystals suitable for X-ray diffraction studies were obtained after recrystallisation from MeCN (slow evaporation under reduced pressure).
1662-01-7, 1662-01-7 4,7-Diphenyl-1,10-phenanthroline 72812, acatalyst-ligand compound, is more and more widely used in various fields.
Reference£º
Article; Nikolaevskii, Stanislav A.; Evstifeev, Igor S.; Kiskin, Mikhail A.; Starikova, Alyona A.; Goloveshkin, Alexander S.; Novikov, Valentin V.; Gogoleva, Natalya V.; Sidorov, Alexey A.; Eremenko, Igor L.; Polyhedron; vol. 152; (2018); p. 61 – 72;,
Metal catalyst and ligand design
Ligand Template Strategies for Catalyst Encapsulation – NCBI